Haemonetics Corporation (HAE) のトレーリングPERは 15.6, 予想PER 12.2. トレーリング益回りは 6.39%, 予想益回り 8.18%. PEG 0.35 (Peter Lynch 割安基準 ≤1.0). グレアム数は $40.54.
このページで証明された基準:
SharesGrow 総合スコア： 77/100 6/7 項目が合格。
| Year | P/E (TTM) | PEG レシオ | P/B レシオ | P/S レシオ | 配当利回り |
|---|---|---|---|---|---|
| 2016 | -32.0 | 0.07 | 2.47 | 1.96 | - |
| 2017 | -79.5 | 1.49 | 2.83 | 2.36 | - |
| 2018 | 84.7 | -0.32 | 5.13 | 4.27 | - |
| 2019 | 84.1 | 3.44 | 6.93 | 4.78 | - |
| 2020 | 66.0 | 1.61 | 8.60 | 5.11 | - |
| 2021 | 70.8 | 17.82 | 7.69 | 6.46 | - |
| 2022 | 74.4 | -1.62 | 4.31 | 3.25 | - |
| 2023 | 36.4 | 0.22 | 5.14 | 3.60 | - |
| 2024 | 36.6 | 16.60 | 4.48 | 3.28 | - |
| 2025 | 19.0 | 0.44 | 3.87 | 2.34 | - |
| Year | EPS（希薄化後） | 売上高 | 純利益 | 純利益率 |
|---|---|---|---|---|
| 2020 | $1.48 | $988.48M | $76.53M | 7.7% |
| 2021 | $1.55 | $870.46M | $79.47M | 9.1% |
| 2021 | $1.55 | $870.46M | $79.47M | 9.1% |
| 2022 | $0.84 | $993.2M | $43.38M | 4.4% |
| 2022 | $0.84 | $993.2M | $43.38M | 4.4% |
| 2023 | $2.24 | $1.17B | $115.4M | 9.9% |
| 2023 | $2.24 | $1.17B | $115.4M | 9.9% |
| 2024 | $2.29 | $1.31B | $117.56M | 9% |
| 2024 | $2.29 | $1.31B | $117.56M | 9% |
| 2025 | $3.31 | $1.36B | $167.68M | 12.3% |
| Year | EPS（平均） | EPS レンジ | 売上高（平均） | 売上高レンジ | アナリスト数 |
|---|---|---|---|---|---|
| 2026 | $4.95 | $4.93 – $4.98 | $1.33B | $1.32B – $1.34B | 8 |
| 2027 | $5.32 | $5.15 – $5.49 | $1.39B | $1.37B – $1.41B | 8 |
| 2028 | $5.93 | $5.52 – $6.17 | $1.49B | $1.49B – $1.49B | 5 |
| 2029 | $6.90 | $6.76 – $7.02 | $1.64B | $1.61B – $1.66B | 3 |
| 2030 | $7.66 | $7.50 – $7.80 | $1.76B | $1.73B – $1.78B | 3 |
